Results
74,396 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Ninan ShibuChief Accounting Officer |  OKTAOkta, Inc.Option exercise | M | — 484 sh | Sep 17, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Ninan ShibuChief Accounting Officer | OKTAOkta, Inc. Option exercise | M | — 484 sh | Sep 17, 2026 |
| 5 | Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS |  AREALEXANDRIA REAL ESTATE EQUITIES, INC.Tax withholding | F | $48K 914 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Derivative conversion | C | $116K 1,332 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 5 | Gossett Bret E.EVP - Co-RMD | AREALEXANDRIA REAL ESTATE EQUITIES, INC. Tax withholding | F | $31K 584 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Gummadi SuryaPresident - Americas |  CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORPOption exercise | M | — 598 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Ninan ShibuChief Accounting Officer | OKTAOkta, Inc. Tax withholding | F | — 247 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Ninan ShibuChief Accounting Officer | OKTAOkta, Inc. Option exercise | M | — 836 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Wetterwald JulienChief Technology Officer |  WLTHWEALTHFRONT CORPOption exercise | M | — 21.1K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Vasquez Alison GautEVP AND CFO |  ORNOrion Group Holdings IncGrant or award | A | $15K 2,000 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Singisetti Ravi KumarDirector, Chief Executive Officer | CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP Option exercise | M | — 5,987 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner |  CRCTCricut, Inc.Open-market sale · 10b5-1 plan | SELL | $333K 60.0K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 4 | Holme TimothyCHIEF TECHNOLOGY OFFICER |  QSQuantumScape CorpOpen-market sale · 10b5-1 plan | SELL | $382K 75.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Choudary Kiran KumarChief Financial Officer |  RBRKRubrik, Inc.Option exercise · 10b5-1 plan | M | — 4,000 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Open-market sale · 10b5-1 plan | SELL | $337K 60.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Inrig JulaEVP, Head of R&D & CMO |  TVTXTravere Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 32.4K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Open-market sale · 10b5-1 plan | SELL | $341K 60.0K sh | Sep 17, 2026 traded Sep 17, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 200 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $20K 200 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 3 | Kenneweg JohnSVP, Sales & Product Marketing |  MASS908 Devices Inc.Option exercise · 10b5-1 plan | M | $21K 21.4K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $32K 300 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 400 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Option exercise | M | — 3,520 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Calvin SandraSVP, CHIEF ACCOUNTING OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $69K 2,500 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Tax withholding | F | — 1,818 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Option exercise | M | — 3,873 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $349K 20.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Bicket JohnDirector, SEE REMARKS, 10% Owner |  IOTSamsara Inc.Derivative conversion | C | — 305.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Tax withholding | F | — 1,525 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Tax withholding | F | — 1,386 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 1 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS |  TBPHTheravance Biopharma, Inc.Open-market sale · 10b5-1 plan | SELL | $113K 6,657 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 1 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | TBPHTheravance Biopharma, Inc. Open-market sale · 10b5-1 plan | SELL | $57K 3,329 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 1 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Tax withholding · 10b5-1 plan | F | $1.40M 14.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 1 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | TBPHTheravance Biopharma, Inc. Open-market sale · 10b5-1 plan | SELL | $57K 3,328 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 0 | Tariq MusaDirector |  GHGuardant Health, Inc.Option exercise · 10b5-1 plan | M | — 249 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 0 | McClymont DonaldDirector, Chief Executive Officer |  INDIindie Semiconductor, Inc.Option exercise · 10b5-1 plan | M | — 50.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 0 | Holme TimothyCHIEF TECHNOLOGY OFFICER | QSQuantumScape Corp Derivative conversion · 10b5-1 plan | C | — 22.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 0 | Kenneweg JohnSVP, Sales & Product Marketing | MASS908 Devices Inc. Option exercise · 10b5-1 plan | M | — 21.4K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 0 | Calvin SandraSVP, CHIEF ACCOUNTING OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 2,500 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary |  VGVenture Global, Inc.Option exercise · 10b5-1 plan | M | — 239.3K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 0 | Kirchhoff Benjamin LouisCHIEF ACCOUNTING OFFICER | IOTSamsara Inc. Tax withholding · 10b5-1 plan | F | $65K 1,514 sh | Sep 17, 2026 traded Sep 15, 2026 |